StageZero Life Sciences Ltd. — Regulatory Filings 2020

Nov 27, 2020

==> picture [165 x 56] intentionally omitted <==

November 26, 2020

Ontario Securities Commission Alberta Securities Commission

British Columbia Securities Commission

Dear Sirs / Mesdames:

Re: Short form prospectus for the offering of units consisting of common shares and common share purchase warrants of StageZero Life Sciences, Ltd.

We refer to the short form prospectus of StageZero Life Sciences, Ltd. (the "Company"), formerly known as GeneNews, Ltd. dated November 26, 2020 relating to the sale and issuance of units consisting of common shares and common share purchase warrants of the Company.

We consent to being named and to the use, through incorporation by reference in the above-mentioned short form prospectus, of our report, dated April 3, 2019 to the shareholders of the Company on the following financial statements:

• Consolidated statements of financial position as at December 31, 2018 and 2017; and

• Consolidated statements of loss and comprehensive loss, changes in shareholders’ equity and cash flows for the years ended December 31, 2018 and 2017, and a summary of significant accounting policies and other explanatory information.

The report to the shareholders of the Company of the subsequent auditor dated May 19, 2020 on the consolidated financial statements for the year ended December 31, 2019 contains an Emphasis of MatterRestated Comparative Information paragraph, which explains restated comparative information and the effects of the adjustments to retroactively restate amounts as disclosed in Note 20 of those consolidated financial statements.

We report that we have read the short form prospectus and all information specifically incorporated by reference therein and have no reason to believe that there are any misrepresentations in the information contained therein that are derived from the financial statements upon which we have reported or that are within our knowledge as a result of our audit of such financial statements. We have complied with Canadian generally accepted standards for an auditors’ consent to the use of a report of the auditor included in an offering document, which does not constitute an audit or review of the prospectus as these terms are described in the CPA Canada Handbook – Assurance.

Yours truly,

==> picture [148 x 40] intentionally omitted <==

==> picture [371 x 58] intentionally omitted <==